arrow
P

Piers Gaunt

university of birmingham
H指数:15
被引数:2,642

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Addition of zoledronic acid to consolidation chemotherapy in Ewing sarcoma—EURO EWING 2012 (EE2012): an international, open-label, randomised controlled phase III trial

在Ewing肉瘤中,将唑来膦酸加入巩固化疗—EURO EWING 2012 (EE2012):一项国际、开放标签、随机对照的III期临床试验

2026-03-150
PRE
PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial

Pet-ct引导,基于症状,患者发起的监测与头颈癌患者的临床随访 (PETNECK2): 多中心可行性研究和非劣效性,随机,III期试验的研究方案

2024-07-101
OAAI
Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments)
2022-09-0119
OAAI
Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial
2017-09-0117
OAAI
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

利拉鲁肽对非酒精性脂肪性肝炎 (LEAN) 患者的安全性和有效性: 一项多中心、双盲、随机、安慰剂对照2期研究

LANCET
IF88.5
2016-02-011.5K
OAAI